Palliative Management of Inoperable Malignant Bowel Obstruction
Status:
Recruiting
Trial end date:
2023-03-07
Target enrollment:
Participant gender:
Summary
To identify the role of palliative medical management of inoperable malignant bowel
obstruction (MBO) with Octreotide, Dexamethasone and Metoclopramide given together as triple
therapy.